Search results
Acer Therapeutics Inc. (ACER) Reports Q1 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoAcer Therapeutics Inc. (ACER) delivered earnings and revenue surprises of -172.22% and 100%,...
Acer Therapeutics Inc. (ACER) Upgraded to Strong Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 1 year agoAcer Therapeutics Inc. (ACER) might move higher on growing optimism about its earnings prospects,...
Acer Therapeutics Inc. (ACER) Dips More Than Broader Markets: What You Should Know
Zacks via Yahoo Finance· 1 year agoAcer Therapeutics Inc. (ACER) closed at $2.39 in the latest trading session, marking a -0.83% move...
Acer Therapeutics Inc. (ACER) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 year agoAcer Therapeutics Inc. (ACER) closed the most recent trading day at $2.28, moving -1.72% from the...
Trade Alert: The Founder Of Acer Therapeutics Inc. (NASDAQ:ACER), Christopher Schelling, Has Just...
Simply Wall St. via Yahoo Finance· 1 year agoThose following along with Acer Therapeutics Inc. (NASDAQ:ACER) will no doubt be intrigued by the...
Is Acer Therapeutics (ACER) Stock Outpacing Its Medical Peers This Year?
Zacks via Yahoo Finance· 1 year agoInvestors interested in Medical stocks should always be looking to find the best-performing...
Are Medical Stocks Lagging Acer Therapeutics (ACER) This Year?
Zacks via Yahoo Finance· 1 year agoThe Medical group has plenty of great stocks, but investors should always be looking for companies...
Acer Therapeutics Expands ACER-801 Development Into Post-Traumatic Stress Disorder
Benzinga via Yahoo Finance· 2 years agoAcer Therapeutics Inc (NASDAQ: ACER) expanded ACER-801 (osanetant) into a new indication for the...
New Strong Sell Stocks for May 27th
Zacks via Yahoo Finance· 2 years agoHere are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Acer Therapeutics Inc. ACER is a pharmaceutical company that develops...
Acer (ACER) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoWe expect investors to focus on updates of Acer Therapeutics’ ACER pipeline and revenue guidance for...